Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Starting Zepbound can sometimes trigger mild mood dips during the first month, but persistent or worsening symptoms beyond four weeks, including loss of interest, fatigue or thoughts of self harm, should prompt you to consult a healthcare provider. Tracking daily mood changes with a simple checklist can help you distinguish normal adjustment blues from more serious depression.
See below for the full checklist, red flags to watch for, lifestyle tips, and next steps to support your emotional well being while on Zepbound.
Zepbound Depression Checklist: Is It a Red Flag?
Starting a new medication can bring relief—but also unexpected changes. Zepbound (tirzepatide) is approved for chronic weight management and type 2 diabetes control. While its most common side effects involve gastrointestinal upset, some patients report mood shifts, including feelings of sadness or low mood, after starting Zepbound. It's natural to wonder: "Is feeling down after Zepbound a red flag?"
Below is a clear, step-by-step checklist to help you track mood changes after beginning Zepbound. Use it to decide if you're experiencing typical adjustment symptoms or if you should seek professional help.
Ask yourself:
Typical patterns:
Mark any symptoms you notice daily. A cluster of these for more than two weeks may indicate clinical depression:
If you check four or more symptoms on most days, it's time to pay close attention.
Adjustment period (first 2–4 weeks):
Signs of clinical depression:
Seek immediate help if you experience:
Call emergency services or go to the nearest emergency department if any of these arise.
Your doctor can:
If depression is diagnosed, your provider may suggest:
Combining medical and psychological support often yields the best outcomes.
While concerns about depression are valid, remember:
Starting Zepbound can be a positive step toward better health—but pay attention to your emotional well-being along the way. Tracking mood changes and knowing when to seek help can make all the difference. If you notice persistent or severe depression symptoms, don't wait. Speak to a doctor or mental health professional right away to ensure you're safe and supported.
(References)
* Risk of Suicidal Thoughts and Behaviour With GLP-1 Agonists: A Systematic Review and Meta-Analysis. Ghandour R, Aoude R, Youssef J, et al. Diabetes Metab Syndr Obes. 2024 Jan 8;17:153-162. doi: 10.2147/DMSO.S440268. PMID: 38202996; PMCID: PMC10784381.
* Safety of Tirzepatide in Patients with Type 2 Diabetes and/or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Lin K, Zhang Y, Tan Q, et al. Diabetes Ther. 2024 Feb;15(2):237-266. doi: 10.1007/s13300-023-01604-x. Epub 2024 Jan 12. PMID: 38320478; PMCID: PMC10842217.
* Tirzepatide: A Review in Type 2 Diabetes and Obesity. Markham A. Drugs. 2023 May;83(7):645-661. doi: 10.1007/s40265-023-01869-7. Epub 2023 Apr 6. PMID: 37022137; PMCID: PMC10129712.
* Psychiatric adverse effects associated with glucagon-like peptide-1 receptor agonists: an analysis of the FDA Adverse Event Reporting System (FAERS) database. Sun X, Huang C, Zhang Y, et al. Front Pharmacol. 2021 Aug 26;12:733190. doi: 10.3389/fphar.2021.733190. PMID: 34543161; PMCID: PMC8427189.
* Semaglutide and tirzepatide for obesity: a narrative review of current evidence and future directions. Ahmad R, Hameed T, Saleem Y, et al. Cureus. 2023 Apr;15(4):e37340. doi: 10.7759/cureus.37340. PMID: 37166318; PMCID: PMC10166258.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.